India set to approve its first Covid vaccine; nationwide dry run tomorrow

A day ahead of the nationwide Covid-19 vaccination dry run, the Indian drug regulator’s expert panel on Friday cleared the decks for emergency use authorisation for the vaccine developed by AstraZeneca and Oxford University. The vaccine, which is being produced locally under the name of Covishield by Serum Institute of India, will now be given the final go-ahead by DGCI.A day ahead of the nationwide Covid-19 vaccination dry run, the Indian drug regulator’s expert panel on Friday cleared the decks for emergency use authorisation for the vaccine developed by AstraZeneca and Oxford University. The vaccine, which is being produced locally under the name of Covishield by Serum Institute of India, will now be given the final go-ahead by DGCI.